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Abstract
Background: When grown in three-dimensional (3D) cultures, epithelial cells typically form cystic
organoids that recapitulate cardinal features of in vivo epithelial structures. Characterizing essential
cell actions and their roles, which constitute the system's dynamic phenotype, is critical to gaining
deeper insight into the cystogenesis phenomena.
Methods: Starting with an earlier in silico epithelial analogue (ISEA1) that validated for several
Madin-Darby canine kidney (MDCK) epithelial cell culture attributes, we built a revised analogue
(ISEA2) to increase overlap between analogue and cell culture traits. Both analogues used agent-
based, discrete event methods. A set of axioms determined ISEA behaviors; together, they specified
the analogue's operating principles. A new experimentation framework enabled tracking relative
axiom use and roles during simulated cystogenesis along with establishment of the consequences
of their disruption.
Results: ISEA2 consistently produced convex cystic structures in a simulated embedded culture.
Axiom use measures provided detailed descriptions of the analogue's dynamic phenotype.
Dysregulating key cell death and division axioms led to disorganized structures. Adhering to either
axiom less than 80% of the time caused ISEA1 to form easily identified morphological changes.
ISEA2 was more robust to identical dysregulation. Both dysregulated analogues exhibited
characteristics that resembled those associated with an in vitro model of early glandular epithelial
cancer.
Conclusion: We documented the causal chains of events, and their relative roles, responsible for
simulated cystogenesis. The results stand as an early hypothesis–a theory–of how individual MDCK
cell actions give rise to consistently roundish, cystic organoids.
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How single cells proliferate and organize into liquid filled
cysts, or acini, is a central question in epithelial morpho-
genesis and cancer research. Epithelial cells in tissues
engage an array of activities to attain acinar structures [1].
The same is true in cultures. When grown embedded in
3D culture, epithelial cells such as Madin-Darby canine
kidney (MDCK) cells develop stereotypical cystic orga-
noids by mechanisms that can differ depending on culture
conditions [2]. When manipulated or exposed to certain
factors, these organoids and composing cells can exhibit
phenotypic attributes that are reminiscent of pre-cancer-
ous or cancerous tissues [3]. While MDCK culture models
are orders of magnitude simpler than epithelial cells in tis-
sues, they provide an appropriate physiological environ-
ment to study epithelial cyst development, function, and
pathology. However, they too are complex dynamic sys-
tems that have proven challenging to understand.
The emergence of stable organoid structures is the cumu-
lative consequence of individual cell actions: the system's
dynamic phenotype. Disruption of one or more of these
actions can cause potentially pathologic changes. Little is
known about the varying cell mechanisms and activities
that engage in different stages of cystogenesis and how
they contribute to the process. A strategy to understanding
the phenomena must include classifying those essential
cell actions and tracing their relative use and roles as the
process unfolds. With time-lapse, microscopy images
alone, it can be difficult to ascertain what cell actions are
responsible for the observed structure transformations.
Computational methods detailed herein represent an
additional, synergistic approach to gain the much-needed
insight. The approach used [4-6] is an example of execut-
able biology [7,8]. We used in silico epithelial analogues
(ISEAs) that have undergone validation against a targeted
set of MDCK epithelial cell attributes. As discussed in [9],
the attributes targeted by the earlier analogue (ISEA1)
were selected to reflect essential MDCK cell behaviors in
cultures but for simplicity, the list excluded other MDCK
attributes. Our goal was to improve ISEA1 in stages to
achieve increased phenotype overlap between the revised
analogue (ISEA2) and MDCK cell cultures. To keep
improvement parsimonious, we expanded the original list
by one additional attribute: all stable cyst structures must
have a convex contour without irregular margins or dim-
ples. Unlike its referent, ISEA1 frequently produced cyst
structures having irregular shapes. Through exploratory
simulations discussed below, we discovered and added
one new cell action to achieve the additional attribute.
The mappings from in silico components, their spatial
arrangement, their mechanisms of interactions, and sys-
tem-level attributes to their in vitro counterparts (Figure
1) improved following that refinement.
Cell biologists compare and contrast the growth charac-
teristics of different, related epithelial cell lines in part to
better understand how and where their behaviors differ or
are similar. That knowledge can be used to make better
inferences about referent cell behaviors in vivo. A proven
wet-lab approach is to design and conduct experiments to
test hypotheses about cell line responses to interventions,
such as blocking a signaling pathway or a cell surface
receptor. Analogous methods must be used to study and
compare phenotypic attributes of in silico analogues, such
as ISEA1 and ISEA2. In addition, study of analogue
responses to interventions improves insight into MDCK
morphogenesis. Differences in morphological and
dynamic phenotype, or lack thereof, between two ana-
logues could shed additional insight on those of the refer-
ent [10]. With that in mind, we compared ISEA1 and
ISEA2 behaviors to understand how specific mechanistic
changes alter their morphogenetic attributes.
ISEA1 and ISEA2 used sets of rules in the form of axioms
for determining CELL action based on CELL neighbor type
and configuration. Each simulation cycle, each CELL
assessed the current arrangement of neighbors, selected
the corresponding axiom, and then executed that axiom's
action. By adhering strictly to their axioms, both ana-
logues achieved their respective set of targeted attributes.
Are actions of MDCK cells in cultures (and epithelial cells
in general) so rigidly choreographed? How tightly must
ISEA adhere to its operating principles before aspects of
phenotype become measurably abnormal? We gained
insight into plausible answers by systematically relaxing
two, key ISEA actions and exploring in detail the pheno-
typic consequences. One action mapped to anoikis, a spe-
cific category of cell death. The other involved directed
placement of an ISEA daughter cell, a form of oriented cell
division. The ISEA1 phenotype was quite sensitive to dys-
regulating the two actions: engaging in either action less
than 80% of the time caused easily detected phenotypic
changes. Interestingly, ISEA2 was more robust to identical
disruptions. Both ISEA1 and ISEA2 exhibited phenotypes
that resembled those associated with an in vitro model of
early glandular epithelial cancer. To the extent that the in
silico-to-in vitro mappings in Figure 2 are valid, ISEA2's
operating principles and dynamic phenotype stand as
hypotheses of their MDCK counterparts in cell culture.
Methods
In vitro cell culture experiments
Full details of the original MDCK cell culture experiments
are provided in [11]. Briefly, MDCK cells were triturated
into single-cell suspensions in type I collagen gel. Cells
were grown for 7–10 d until cysts with lumina formed. For
immunofluorescence staining of cysts, samples were incu-
bated with primary antibodies overnight, followed by an
overnight incubation with fluorescent dye-labeled sec-Page 2 of 21
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Relationships between analogues and MDCK culturesFigure 1
Relationships between analogues and MDCK cultures. To distinguish simulation components and characteristics from 
in vitro counterparts, we use small caps when referring to the former. An in silico epithelial analogue (ISEA) is comprised of 
autonomous CELL components interacting with adjacent CELLS and environment components. Interactions are governed by a 
set of axiomatic operating principles (rules). For each environment circumstance a CELL can encounter, there is a correspond-
ing axiom. A clear mapping exists between ISEA components (CELL states and environment components) and in vitro counter-
parts. Following execution, interacting components cause local and systemic behaviors. Measures of CELL and system behaviors 
(growth rates, structure type, etc.) are the in silico attributes. Validation occurs when a set of ISEA attributes is measurably 
similar to a corresponding, prespecified set of in vitro attributes. Upon validation, we can hypothesize that a semiquantitative 
mapping exists between ISEA events and in vitro events, and that the set of in silico operating principles has a biological coun-
terpart.
Theoretical Biology and Medical Modelling 2009, 6:8 http://www.tbiomed.com/content/6/1/8Figure 2 (see legend on next page)Page 4 of 21
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stained for gp135 (apical surface), β-catenin (basolateral
surface) and nuclei, and then visualized using a confocal
microscope.
In silico experimentation framework
ISEA1 and ISEA2 are discrete event [12], agent-based [13]
systems that comprise the core analogue and system-level
components for experimentation and analysis (Figure 2).
Because ISEA2 is based on ISEA1, both share a common
design, and their experiment features overlap significantly
(discussed below). Before moving forward with model
refinement and experimentation, implementation redun-
dancies of ISEA1 and ISEA2 were removed. We revised the
existing framework to enable simulation of multiple,
somewhat different CELL analogue types. ISEA1 was
ported and revalidated within the new framework prior to
ISEA2 development. To clearly distinguish ISEA compo-
nents and processes from their in vitro counterparts, here-
after we use small caps when referring the former.
We created system-level components including EXPERI-
MENT MANAGER, OBSERVER, and CULTURE graphical user
interface (GUI) to enable semi-automated experimenta-
tion and analysis. EXPERIMENT MANAGER, the top-level sys-
tem component, is an agent that provides experiment
protocol functions and specifications. The specifications
define the mode of experimentation and the system's
parameter vector. Experiments can be conducted in
default, visual, or batch modes. Batch mode enables auto-
matic construction and execution of multiple experi-
ments, as well as processing and analysis of recorded
measurements. Based on user-defined specifications,
EXPERIMENT MANAGER automatically generates a set of
parameter files and executes a batch of experiments, each
corresponding to a different parameter file. After comple-
tion of all experiments, basic analytic operations collect
and summarize data. OBSERVER is responsible primarily
for recording measurements. At the end of every simula-
tion cycle, OBSERVER scans the CULTURE internals and per-
forms measurements. The measurements are recorded as
time series vectors. At simulation's end, data are written to
a set of files for analytic processing by EXPERIMENT MAN-
AGER. CULTURE GUI provides a visualization console,
which can be used interactively to start or pause a simula-
tion and to access live states of CULTURE grid content.
Using CULTURE GUI functionalities, OBSERVER can capture
time-lapse CULTURE images and store them in multiple for-
mats for post-processing.
ISEA1 and ISEA2 designs are agent-based and object-
oriented
Detailed descriptions of ISEA1 design features, and devel-
opment methods, are available in [9]. ISEA2 design uses
similar features, which have been refined to meet study
requirements. An abridged description follows. The refer-
ent in vitro cell culture was conceptually abstracted into
four components: cells, media containing matrix (matrix
hereafter), matrix-free media (free space hereafter), and a
space to contain them. Discrete software objects with
eponymous names represent those four essential cell cul-
ture components: CELL, MATRIX, FREE SPACE, and CULTURE.
MATRIX and FREE SPACE are passive objects. A MATRIX object
maps to a cell-sized volume of extracellular matrix (ECM).
A FREE SPACE object maps to a similarly sized volume of
material that is essentially free of cells and matrix ele-
ments. FREE SPACE also represents luminal space and non-
matrix material in pockets enclosed by cells. The latter are
called LUMINAL SPACE when distinction from FREE SPACE is
useful. CELLS are quasi-autonomous agents (as agents,
they can schedule their own events; they follow their own
agenda). They use a set of rules or decision logic to interact
with their local environment. A CULTURE is an agent that
maps abstractly to a cell culture within one well of a multi-
well culture plate. The CULTURE uses a standard two-
dimensional (2D) hexagonal grid to provide the space in
which its objects reside. The grid has toroidal topologies.
For simplicity, each grid position is occupied by one
object. That condition can be changed when the need
arises.
ISEA components and system architectureFigure 2 (see previous pag )
ISEA components and system architecture. The in silico system consists of a CULTURE and framework components. 
MDCK cell cultures and ISEAs are both composite systems. A CULTURE represents one in vitro cell culture. It is a composite of 
three object types: CELLS, MATRIX, and FREE SPACE. A hexagonal grid provides the space (CULTURE space) within which compo-
nents interact. CELLS are quasi-autonomous agents whose actions are driven by their internal logic and a set of axiomatic oper-
ating principles. MATRIX maps to extracellular matrix, and FREE SPACE maps to aqueous material (e.g., cyst lumen) devoid of cells 
and matrix. Both are passive objects. ISEA1 [9] validated for basic, target attributes of four different cell culture types: embed-
ded, suspension, surface, and overlay. ISEA1 was revised to ISEA2, which validated for an expanded set of target attributes. The 
framework provides components and methods to enable semi-automatic experimentation and analysis. EXPERIMENT MANAGER is 
the experiment control agent. It prepares parameter files, manages experiments, and processes data. OBSERVER is a module 
that automatically conducts and records measurements on CULTURE. CULTURE GUI provides a graphical interface to visualize 
and interactively probe CULTURE during execution.Page 5 of 21
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detail—granularity—and the list of targeted attributes.
Granularity is the extent to which a larger entity is subdi-
vided. There is also a direct link between required mecha-
nistic detail and granularity. We can discover that a cell
always (or almost always) executes a particular move
when confronted with a specific situation without know-
ing (or needing to represent) details of how the move was
accomplished. Our goal has been to first discover plausi-
ble cell-level mechanistic details that account for a variety
of targeted attributes; cell size is thus a logical granularity
level. We can then explore more detailed (fine-grained)
explanations for how a particular mechanistic detail was
enabled, because a coarse-grained component can be
replaced by a finer-grained component when that is
needed. A more coarse-grained mechanism that can
account for targeted attributes is preferred over a more
detailed mechanism because the coarse-grained mecha-
nism is simpler. The parsimony guideline is to prefer the
simpler explanation of the facts (the targeted attributes).
ISEA execution protocol
A CULTURE has base methods that are called automatically
at a simulation's start and end. The start function initial-
izes the grid and CULTURE components, CELLS, MATRIX, and
FREE SPACE. Simulation starts upon completion of that
process. As execution advances, the event schedule is
stepped for a number of simulation cycles or until a stop
signal is produced. At simulation's end, the CULTURE finish
function closes open files and clears the system.
Simulation time advances discretely, and is maintained by
a master event schedule. Event ordering within a simula-
tion cycle is pseudo-random. Having objects update
pseudo-randomly simulates the parallel operation of cells
in culture and the nondeterminism fundamental to living
systems, while building in a controllable degree of uncer-
tainty. Within a simulation cycle, each CELL in pseudo-ran-
dom order is given an opportunity to interact with
adjacent objects in its environment and, if required,
undertake an action. Every CELL uses the same step func-
tion. A set of CELL axioms (Figure 3) determines all CELL
actions. A CELL selects just one axiom and corresponding
action during each simulation cycle.
Axiomatic operating principles
An agent has rules and protocols for interacting with exter-
nal components. Rules can take any form. We elected to
have all rules take the form of axioms. We use the term
"axiom" to reinforce an idea that our computational
model is a mathematical, formal system and that ana-
logue execution is a form of deduction from the original
axioms or assumptions explicitly programmed into the
model. An axiom specifies a precondition and corre-
sponding action. We specified what we judged to be a
minimal set of action options: replace an adjacent non-
CELL object with a CELL copy, DIE (vanish) and leave
behind a LUMINAL SPACE, create MATRIX, destroy an adjacent
non-CELL object and move to that location leaving behind
a LUMINAL SPACE, POLARIZE, DEPOLARIZE, and do nothing.
For any precondition, only one action option was exe-
cuted.
ISEA1 had eleven axiomatic operating principles that ena-
bled the analogue to validate against its initial targeted
attributes. For convenience, the final ISEA1 axioms are
summarized as follows. The precondition applies to the
six objects adjacent to each CELL.
1. All neighbors are CELLS: DIE (delete self) and leave
behind a LUMINAL SPACE.
2. All neighbors are LUMINAL SPACE: DIE and leave behind a
LUMINAL SPACE.
3. All neighbors are MATRIX: replace a randomly selected
MATRIX with a CELL copy.
4. Neighbors comprise one CELL and LUMINAL SPACES: add
MATRIX between self and the adjoining CELL.
5. Neighbors comprise at least two CELLS and LUMINAL
SPACES, but no MATRIX: DIE (undergo ANOIKIS) and leave
behind a LUMINAL SPACE.
6. Neighbors comprise at least one CELL and MATRIX: create
a CELL copy; the copy replaces any MATRIX that maximizes
its number of CELL neighbors.
7. Neighbors comprise at least two LUMINAL SPACES and
MATRIX: create a CELL copy; the copy replaces any LUMINAL
SPACE that adjoins MATRIX.
8. Neighbors comprise CELLS, MATRIX, and at least two
adjacent LUMINAL SPACES: create a CELL copy; the copy
replaces any LUMINAL SPACE neighbor that adjoins MATRIX
and LUMINAL SPACE.
9. Two CELL neighbors are separated on one side by MATRIX
and on the other side by LUMINAL SPACE: POLARIZE.
10. A POLARIZED CELL has noncontiguous MATRIX neigh-
bors: revert to NONPOLARIZED CELL state.
11. None of the preceding preconditions has been met: do
nothing; CELL mandates achieved.
Detailed descriptions of supporting biological evidence
and assumptions made for ISEA1 CELL axioms are pro-
vided in [9]. Briefly, CELL DEATH axioms (Axioms 1, 2, andPage 6 of 21
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such as epithelial cells, undergo a process of cell death
within some interval after detaching from ECM [14,15].
That behavior is observed in MDCK cell cultures [2,16].
Axiom 4, which dictates MATRIX deposition between two
adjacent CELLS, was specified based on observations that
some matrix is produced de novo between two adhering
MDCK cells in suspension culture [17]. A CELL DIVISION
axiom, Axiom 3, follows from experimental observations
that, when embedded in matrix, single MDCK cells prolif-
erate [11,16]. Other CELL DIVISION axioms, Axioms 6, 7,
and 8, follow from a similar, general principle that epithe-
lial cells proliferate when they adhere to ECM and tend do
so in arrangements that maximize intercellular contact
[18,19]. CELL POLARIZATION axioms, Axioms 9 and 10,
reflect in vitro observations on MDCK cell polarity [2,18].
Axiom 11 applied when the CELL achieved mandates that
map to the three-surfaces principle articulated in [1,18].
Starting with the ISEA1 axioms, we devised, tested, and
iteratively refined candidate axioms to enable the CELLS to
consistently develop CYSTS with smooth margins and a
convex shape (in the hexagonal grid representation),
while validating for the targeted attributes described in
[9]. At each step, variations of an axiom were tested, and
those that moved the analogue closer to validation were
ISEA2 CELL decision logic and axiomatic operating principlesFigure 3
ISEA2 CELL decision logic and axiomatic operating principles. Simulation time advances by simulation cycles. During a 
simulation cycle, every CULTURE component is given an opportunity to update. Every CELL in a pseudo-random order decides 
what action to take based on its internal state (POLARIZED or UNPOLARIZED) and the composition of its adjacent neighborhood. 
Actions available to UNPOLARIZED CELLS are: DIE, create a new CELL, produce MATRIX, POLARIZE, and do nothing. POLARIZED CELLS 
have three options: DEPOLARIZE, reposition, or do nothing. At every decision point, the CELL uses the diagrammed logic to 
select and execute just one action. We iteratively refined ISEA1 to ISEA2. It consistently produced convex, cystic structures in 
addition to achieving the original set of targeted attributes.Page 7 of 21
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ISEA2 used Axioms 1–10 from ISEA1 without change.
However, ISEA1's Axiom 11 was replaced by the following
two axioms.
11. Neither the preceding nor the following preconditions
have been met: do nothing; CELL mandates achieved.
12. A POLARIZED CELL confirms that Axiom 9 precondition
is met and has only one MATRIX neighbor: the POLARIZED
CELL deletes the adjacent MATRIX, moves to its location,
and leaves behind a LUMINAL SPACE.
The revised axioms diagrammed in Figure 3 and summa-
rized in Table 1 represent what we determined as a mini-
mal change that was required for final validation.
Revisions that were more elaborate also enabled those
ISEAs to achieve the target attributes. However, they were
rejected because they were not parsimonious. The final
validation required that > 98% of the CYSTS formed during
50 simulation cycles in 100 Monte Carlo simulations
must have a roundish, convex shape (visually inspected).
We determined by visual inspection that convex CYSTS had
no dimples or irregular margins. Manual inspection of the
ISEA CYSTS sufficed for this study's purposes. However, we
will need algorithmic metrics to expedite and automate
analyzing and quantifying CYST convexity.
Operational disruption of ISEA CELL axioms
We implemented a method to disrupt selectively the oper-
ation of individual CELL axioms. We added a parameter, p,
for each axiom. It controlled the probability of the deci-
sion-making CELL electing to follow the axiom when its
precondition applied. Parameter values ranged from 0 to
1 inclusively. A parameter value = 1 corresponded to
100% adherence. Setting it to zero completely blocked the
prescribed action and, as specified, dictated an alternate
action. An additional control was added to allow the CELL
Table 1: ISEA CELL axioms and consequences of dysregulated CELL actions.
Axiom Precondition Action Dysregulated action Observed morphological changes
1 CELLS only DIE Do nothing None (p > 0); unchecked growth (p 
= 0)
2 LUMINAL SPACE only DIE Do nothing None (p ≥ 0)
3 MATRIX only DIVIDE non-directionally Do nothing None (p ≥ 0)
4 1 CELL and LUMINAL SPACES; no 
MATRIX
Produce and deposit MATRIX Do nothing None (p ≥ 0)
5 ≥ 2 CELLS and LUMINAL SPACE; no 
MATRIX
DIE Do nothing Increased CELL population; nested 
CELL CLUSTERS in CYST LUMEN (p < 1)
6 ≥ 1 CELL and MATRIX; no LUMINAL 
SPACE
DIVIDE directionally DIVIDE in a random direction Increased CELL population; nested 
CELL CLUSTERS in CYST LUMEN (p < 1)
7 MATRIX and ≥ 2 LUMINAL SPACES; no 
CELLS
DIVIDE directionally DIVIDE in a random direction None (p ≥ 0)
8 CELLS, MATRIX, and ≥ 2 adjacent 
LUMINAL SPACES
DIVIDE directionally N/A N/A
9 2 CELLS, MATRIX, and LUMINAL SPACE; 
POLARIZING condition*
POLARIZE N/A N/A
10 DEPOLARIZING condition† DEPOLARIZE N/A N/A
11 All other configurations Do nothing N/A N/A
12 POLARIZING condition; 1 MATRIX Move and replace the 
neighboring MATRIX
Do nothing Frequently irregular, nonconvex 
CYST shape (p < 1)
Each axiom's precondition takes into consideration the six objects adjacent to the decision-making CELL. In dysregulated state, the normal CELL 
action applies with probability p; the dysregulated CELL action applies with probability 1 - p. Exploration of Axioms 8–11 was beyond the scope of 
this study. Axiom 12 is used only by ISEA2.
* Two CELL neighbors separate MATRIX on one side from LUMINAL SPACE on the other side. †A POLARIZED CELL has noncontiguous MATRIX neighbors.Page 8 of 21
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ard uniform distribution at each decision point. The
axiom's prescribed action was followed only when the
PRN was ≤ the probability threshold set by its parameter.
We considered, and used when applicable, alternative
actions that map to plausible in vitro cell actions occur-
ring in a dysregulated state (Table 1). Axioms 1, 2, and 5
governed CELL DEATH; a reasonable alternative was to
remain ALIVE (i.e., do nothing). Axiom 3 dictated non-
directional CELL DIVISION; its alternate action was to do
nothing (i.e., prevent REPLICATION). We also assigned the
alternate action of 'do nothing' to Axiom 4 (MATRIX pro-
duction). Several dysregulated action options were availa-
ble for Axiom 6 (directed CELL DIVISION). One was to do
nothing, effectively suppressing CELL DIVISION. Another
was DISORIENTED CELL DIVISION, positing the CELL copy in a
random direction without regard for the number of CELL
neighbors. We elected to use the latter, for which ade-
quate, supportive biological information is available [20-
23]. Axiom 7, which dictated CELL DIVISION, had available
the same alternative action options. Axiom 8 (CELL DIVI-
SION or POLARIZATION) had a precondition comprising all
three component types (CELL, MATRIX, and LUMINAL SPACE),
which presented many plausible action options. One
option was preventing CELL DIVISION; another was to allow
the CELL to DIVIDE non-directionally as described above.
Another option was to initiate POLARIZATION. The remain-
ing axioms, Axioms 9–12, posed a similar problem of hav-
ing many plausible action options. Because no wet-lab
experimental insight was available to narrow the options,
we elected to defer investigation of those axioms until
more information becomes available.
Simulation experiment design
The following describes design and execution of ISEA1
and ISEA2 simulation experiments. First, the top-level sys-
tem component, EXPERIMENT MANAGER, was initialized.
Next, EXPERIMENT MANAGER created a new CULTURE and
filled its grid with MATRIX. The grid width and height were
set to 100. CULTURE initialized a PRN generator with a seed
set to the system's clock. A new seed was used to initialize
the CULTURE'S PRN generator at the start of each simula-
tion. Pseudo-random seeds were generated from the CUL-
TURE'S PRN generator to initialize those used by CELLS.
Following CULTURE grid setup, one CELL was placed at the
center of the CULTURE grid, replacing an existing MATRIX
object. The simulation started when the initialization of
the CULTURE contents was completed. Each simulation
experiment comprised 100 Monte Carlo (MC) runs. Each
MC run was executed for 50 simulation cycles. At simula-
tion's end, the recorded measurements were written to
files and the CULTURE was destroyed. A new CULTURE was
created for each repetition.
Implementation tools
The model framework was implemented using MASON, a
multi-agent, discrete event simulation library, coded in
Java [24]. Batch simulation experiments were performed
on a small-scale Beowulf cluster system. For model devel-
opment, testing, and analysis, we used personal comput-
ers. Computer codes and project files are available at
http://biosystems.ucsf.edu/research_epimorph.html.
Results
To validate against the targeted attributes, a single CELL
was placed in CULTURE space, surrounded by MATRIX. As
simulation progressed, the CELL underwent repeated
rounds of REPLICATION, followed by LUMINAL SPACE forma-
tion and CYST maturation. The LUMINAL SPACE grew as CELLS
in the inner region DIED (and vanished) or moved out-
ward. Growth characteristics were similar to those
observed in MDCK embedded cultures (Figure 4A). CUL-
TURES always formed stable CYSTS bordered by POLARIZED
CELLS (Figure 4B, C). Most ISEA1 CYSTS had irregular
shapes. ISEA2 consistently produced CYSTS having a
roundish, convex shape (Figure 4C). CYSTS in ISEA2 CUL-
TURES stabilized with fewer CELLS (Figure 4D) than did
ISEA1.
For dysregulation experiments, we focused on two critical
CELL axioms, Axioms 5 and 6. Axioms 2, 3, 4, and 7, were
not critical to CYST formation in EMBEDDED CULTURE (they
were critical in other CULTURE conditions, such as monol-
ayer), and were infrequently used, so they were excluded
from detailed analysis. Although not essential for EMBED-
DED CULTURE, Axiom 4 proved to be an important yet rare
event axiom, as discussed below. Disrupting Axiom 8 is
not straightforward: if the axiom is not applied, some
alternative action must follow from its precondition, and
there are many plausible options. We elected not to pur-
sue disruption of Axiom 8 until further insight from wet-
lab studies becomes available to narrow options. Disrupt-
ing Axiom 1 was straightforward, but the results (not
shown) offered no significant insight: CLUSTERS either
developed normally into CYSTS for p > 0 or grew
unchecked as a solid mass when p = 0. We expected that
outcome because Axiom 1 was required for initial LUMINAL
SPACE creation but became nonessential thereafter. On the
other hand, Axioms 5 and 6 were essential to CYST forma-
tion. Anoikis is a form of cell death that epithelial cells
undergo when they lose direct matrix contact [14]. Axiom
5 dictates ANOIKIS. It is the most frequently used CELL
DEATH axiom in both ISEA1 and ISEA2. Axiom 6 dictates
directed CELL creation (the event maps to selective place-
ment of a daughter cell), and accounts for most of the CELL
creation events in both analogues. The in vitro counter-
parts of Axioms 5 and 6 are centrally implicated in epithe-
lial morphogenesis and carcinogenesis, and have beenPage 9 of 21
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Cyst growth in simulated and in vitro MDCK cell cultureFigure 4
Cyst growth in simulated and in vitro MDCK cell culture. (A) MDCK cells grown in 3D matrix form lumen-enclosing 
cystic organoids surrounded by a layer of polarized cells. Cells composing the cysts maintain three surface types: apical (green), 
basal and lateral (red). Note the roundish contour typical of MDCK cysts. For growth and staining details, see [11]. Bar: 10 μm. 
(B) ISEA1 CELLS in EMBEDDED condition produced stable, cystic structures enclosing LUMINAL SPACE; all CELLS were POLARIZED 
(red). Many CYSTS like the one shown, had irregular, non-convex shapes unlike their in vitro counterpart. (C) ISEA2 CELLS 
under the same condition also developed stable CYSTS; almost all stabilized CYSTS had convex shapes. Note that a hexagonal 
CYST within the hexagonally discretized space maps to a roundish cross-section through a MDCK cyst in vitro. (D) ISEA2 CELLS 
formed CYSTS that tended to be smaller than those of ISEA1 (average 27 vs 31 CELLS per CYST). The CELL count represents 
mean values after 50 simulation cycles of 100 Monte Carlo runs.
Theoretical Biology and Medical Modelling 2009, 6:8 http://www.tbiomed.com/content/6/1/8shown to be important in the context of in vitro cell cul-
tures.
Dysregulation of Axiom 5 (ANOIKIS)
In MDCK cultures, apoptosis contributes centrally to
lumen formation [2]. Cells in the inner region of the
developing structure undergo anoikis. We speculated that
if ISEA CELL actions have MDCK counterparts, then the
two analogues would exhibit (predict) LUMEN filling when
ANOIKIS is compromised. We simulated the condition by
disrupting application of Axiom 5. So doing caused aber-
rant growth (Figure 5) and changed CELL activity patterns
(Figure 6). Growth rates increased nonlinearly with
increasing dysregulation. ISEA1 was more sensitive to dys-
regulation at mid-range p of 0.4 and 0.6 than was ISEA2.
No marked differences were noted at other tested levels.
CELL population measurements after 50 simulation cycles
reflected changes in growth (Figure 5C). ISEA2 (vs ISEA1)
produced structures having fewer CELLS.
Visual assessment of sample images showed that the CUL-
TURE morphology became irregular with increased dysreg-
ulation (Figure 7). Relative to ISEA2, irregularities were
more pronounced when ISEA1's Axiom 5 was dysregu-
lated. When CELL creation events outpaced DEATH, small,
inverted CYSTS formed and stabilized (through POLARIZA-
TION) within LUMENS. As dysregulation increased, surface
irregularities postponed POLARIZATION enabling further
CELL creation events and surface expansion. For ISEA2,
other factors contributed to LUMEN clearing. The convexity
drive (Axiom 12) enabled surface CELLS to POLARIZE
sooner. It also retarded inverted CYST formation by CELLS
trapped within LUMENS. Trapped CELLS were thus more
likely to satisfy the precondition of Axiom 5, even when
Axiom 5 was partially dysregulated.
Figure 6 shows how changes in CELL activity patterns
accompanied morphology changes for two levels of
Axiom 5 dysregulation. ANOIKIS dysregulation changed
the occurrence frequencies of axiom preconditions. That
change resulted in increased CELL creation events for both
ISEA1 and ISEA2. Interestingly, for p = 0.8 and 0.6, those
changes led to a net increase in CELL DEATH events. For
ISEA1, many of the additional CELL creation events
occurred along the CYST's outer edge, whereas for ISEA2,
many of the additional CELL creation and DEATH events
occurred within the LUMEN. The CELL creation events
within LUMENS were enabled by the Axiom 4 action: create
MATRIX between two CELLS. Blocking Axiom 4 use blocks
almost all CELL creation events within LUMENS and pro-
motes LUMEN clearance (not shown).
Dysregulation of Axiom 6 (oriented CELL creation)
Oriented cell division is central to multicellular morpho-
genesis [25-27]. Matrix contact and cell adhesions play an
important role in determining the orientation of the divi-
sion axis in vitro [28,29]. Similar to its in vitro counter-
part, CELL creation from Axiom 6 was oriented (not
random). We dysregulated Axiom 6 by allowing the deci-
sion-making CELL to place a new CELL in a randomly
selected MATRIX location, rather than selecting one that
maximizes CELL contact.
Dysregulation of Axiom 5 (ANOIKIS) and its effect on ISEA growth and morphologyFigure 5
Dysregulation of Axiom 5 (ANOIKIS) and its effect on ISEA growth and morphology. Axiom 5 dictates CELL DEATH 
when the decision-making CELL has in its neighborhood at least two CELLS and LUMINAL SPACE but no MATRIX. CELLS followed 
Axiom 5 with a parameter-controlled probability, p. Otherwise, the Axiom 5 precondition produced no CELL DEATH. Evasion of 
Axiom 5 changed ISEA1 and ISEA2 growth and structural characteristics in EMBEDDED CULTURES. (A-B) CELL counts at six levels 
of dysregulation are shown. Values are means of 100 Monte Carlo runs. CELL count increased monotonically with the severity 
of dysregulation. For ISEA2, the effects were less dramatic for larger p. (C) Dysregulation caused a nonlinear increase in both 
ISEA1 and ISEA2 CELL count measured after 50 simulation cycles.Page 11 of 21
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CELL DEATH and creation events by ISEA1 and ISEA2 with and without dysregulation (two levels) of Axioms 5 and 6Figure 6
CELL DEATH and creation events by ISEA1 and ISEA2 with and without dysregulation (two levels) of Axioms 5 
and 6. Values in circles are axiom p values.  Left panels (A–D): ISEA1 events. Right panels (E-H): ISEA2 events. Top four panels: 
CELL creation events. Bottom four panels: CELL DEATH events. Event values are occurrences per simulation averaged over 100 
Monte Carlo runs.
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Typical structures formed by ISEA1 and ISEA2 when Axiom 5 or 6 was dysregulatedFigure 7
Typical structures formed by ISEA1 and ISEA2 when Axiom 5 or 6 was dysregulated. Shown are images of struc-
tures formed after 50 simulation cycles for p = 0.8 and 0.6. Note that a regular hexagon in 2D hexagonal space maps to a circle 
in 2D continuous space. Objects: POLARIZED CELL (red), UNPOLARIZED CELL (gray), MATRIX (white), and LUMINAL SPACE (black). 
(A-B) Shown are examples of structures formed when ISEA1 was dysregulated. (C-D) Shown are examples of structures 
formed when ISEA2 was dysregulated.
Theoretical Biology and Medical Modelling 2009, 6:8 http://www.tbiomed.com/content/6/1/8We ran simulations with Axiom 6's p ranging from 0 to 1,
and recorded changes in CULTURE growth and morphology
along with CELL activity patterns. The overall results are
shown in Figure 8. CULTURE growth rate and CELL count
after 50 simulation cycles increased monotonically with
Axiom 6 dysregulation. The changes were less dramatic
than those observed following Axiom 5 dysregulation,
and there were marked differences between dysregulated
ISEA1 and ISEA2 CULTURE growth. ISEA2 was less suscep-
tible to disoriented placement of a newly created CELL.
Mean CELL count in ISEA2 CULTURES was always smaller
than that for ISEA1 at every tested dysregulation level.
Dysregulating Axiom 6 using p = 0.8 and 0.6 increased
CELL DEATH and CELL PROLIFERATION activities of ISEA2 less
than ISEA1 (Figure 6). CELL DEATH events were offset by an
approximately equal number of CELL creation events, and
that was consistent with the observation that LUMEN-
entrapped CELLS underwent cycles of CELL creation and
DEATH.
Inspection of Figure 7C, D shows that the morphological
irregularities resulting from a given degree of Axiom 6 dys-
regulation were less pronounced than from a correspond-
ing degree of Axiom 5 dysregulation. For ISEA1, the
morphology change produced by a degree of Axiom 6 dys-
regulation was very similar to that caused by a lesser
degree of Axiom 5 dysregulation. ISEA1 structures pro-
duced using dysregulated Axiom 6 contained a larger frac-
tion of POLARIZED CELLS than did corresponding Axiom 5
dysregulated structures, and so the former changed more
slowly as simulations progressed. For ISEA2, because all
CELL DEATH axioms were always followed, there was less
LUMEN filling when Axiom 6 was dysregulated, compared
to when Axiom 5 was disrupted to the same degree. As
noted above, ISEA2 LUMEN filling was enabled by Axiom
4. Blocking it severely restrained and often eliminated for-
mation of INTRALUMINAL CELL CLUSTERS.
Dynamic phenotype
Figure 9 presents dynamic phenotype: the normalized fre-
quency of axiom use by both ISEA1 and ISEA2. The
CYSTOGENESIS mechanism at any stage in the process is the
set of all events occurring within that interval. It is clear
from Figure 9 that there is no specific CYSTOGENESIS mech-
anism. From start to the end of a simulation or until a sta-
ble structure forms, the mechanism evolves. How it
evolves is a feature of that analogue's dynamic phenotype.
Use patterns were similar for those axioms common to
both analogues and that were used most frequently (1, 3,
5, 6, 9, and 11). Major differences were evident only for
the less frequently used axioms (2, 4, 7, 8, and 10). As
noted earlier, enabling CELL movement (Axiom 12) had
an unanticipated consequence: it enabled the occasional
formation of long-lived, small islands of CELLS within a
LUMEN. Once a unit of MATRIX was formed, CELLS within a
LUMEN could move and that gave rise to preconditions for
creation of new CELLS as well as CELL DEATH. The process
can continue for an extended interval and that accounts
for the very low frequency of use of Axioms 2, 4, 7, and 8
by ISEA2. Note that when CELLS are trapped within an oth-
erwise stable CYST, those INTRALUMINAL events are the only
Dysregulation of Axiom 6 and its effect on ISEA CULTURE growthFigure 8
Dysregulation of Axiom 6 and its effect on ISEA CULTURE growth. Axiom 6 dictates oriented placement of a newly 
created CELL. It is placed at an adjacent MATRIX position that maximizes its number of CELL neighbors. CELLS followed Axiom 6 
with a parameter-controlled probability, p. Otherwise, the CELL copy replaced a randomly selected MATRIX neighbor without 
regard for CELL neighbor number. Doing so changed ISEA growth and structural characteristics. (A-B) CELL count increased 
monotonically with the severity of dysregulation. Compared to ISEA1 growth (A), ISEA2 growth was affected less for every 
dysregulation level. (C) CELL count after 50 simulation cycles showed marked differences between ISEA1 and ISEA2 that 
increased with the severity of dysregulation.Page 14 of 21
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Dynamic phenotype: axiom usage by ISEA1 and ISEA2Figure 9
Dynamic phenotype: axiom usage by ISEA1 and ISEA2. Normalized axiom use frequencies are plotted versus simula-
tion cycle. Left panels (A-C): ISEA1 use frequencies. Right panels (D-F): ISEA2 use frequencies. Top: axioms used most fre-
quently. Middle: moderate use events. Bottom: Rare axiom use events. Axiom numbers in circles: the curves are normalized 
use frequencies averaged over 100 Monte Carlo runs. Axiom numbers in pentagons: the variance in average use frequency for 
the rarely used axioms was large; for clarity, trend lines are shown. In B and E, trend lines for Axiom 8 usage are magnified by 
a factor of 5. Raw data are provided in additional file 1: Supplemental Material. As simulations progressed and CYSTS matured, 
Axiom 11 (do nothing) was executed most frequently.
Theoretical Biology and Medical Modelling 2009, 6:8 http://www.tbiomed.com/content/6/1/8events. For that simulation, their relative use frequencies
are large, and it is those values that are averaged with the
values from other simulations, which are typically zero.
If nutrient levels within lumens are less than outside the
cyst, then intraluminal cell division may not be sustaina-
ble. Furthermore, under 3D culture conditions, there is no
direct evidence of matrix production by MDCK cells
trapped within early-stage lumens during cystogenesis. It
is noteworthy that by simulation cycle 50, when Axiom 4
is blocked, ISEA2's use frequency of axioms 2, 7, 8 and 10
drops to zero (not shown): ISEA2's axiom frequency of
use pattern becomes similar to that of ISEA1.
Axiom dysregulation changed dynamic phenotype. Addi-
tional records for dysregulating Axioms 5 and 6 are pro-
vided in additional file 1: Supplemental Material for both
ISEA1 and ISEA2. Because trends are similar for ISEA1 and
ISEA2, we present in Figures 10 and 11 selected results for
ISEA2. Figure 10 shows ISEA2 axiom use frequencies for
Axiom 5 p = 0.8 and 0.6. The major consequence was
reduction in Axiom 11 usage (do nothing: mandates
achieved). That decline was mirrored by the rise in Axiom
5* (dysregulated action) usage, which remained relatively
constant after five simulation cycles. In parallel, the use
patterns for all other axioms changed relative to their p =
1 patterns. Even though only Axiom 5 was disrupted occa-
sionally, all ISEA2 operating principles were impacted to
some extent: the entire dynamic phenotype changed.
However, the morphological consequences for p = 0.8
were difficult to detect: except for a tendency to be larger,
most stabilized CYSTS were indistinguishable from those
formed when p = 1. The potential morphological conse-
quences of relaxing Axiom 5's p by 20% were thwarted by
small shifts in the use frequencies of all other axioms. This
observation suggests that the networked nature of ISEA2
axiom usage acts to buffer the consequences of small dis-
ruptions of any one operating principle.
Both the morphological and dynamic phenotypic conse-
quences of Axiom 6 dysregulation were less dramatic than
those of Axiom 5. They were also less dramatic in ISEA2
than in ISEA1. Reducing p led to larger structures that
eventually stabilized (Figure 8B) and to more CELLS being
trapped within occasional LUMENS (Figure 7D). Compari-
son of Figures 10 and 11 reveals that the influence of
Axiom 6 disruption was also less significant than that of
disrupting Axiom 5 to the same degree. For p = 0.8 and
0.6, the activities of CELLS trapped in LUMENS were prima-
rily responsible for increased axiom use after about 20
simulation cycles. When Axiom 4 was blocked (not
shown), those axiom use frequencies diminished consid-
erably making an increased CYST size the primary conse-
quence of Axiom 6 disruption.
Discussion
We detailed a computational approach to build and test
plausible hypotheses of in vitro dynamic phenotype. The
newly developed framework enabled MDCK cell-mimetic
analogues to function as autonomously as feasible for
software agents. Axiomatic operating principles enabled
ISEA2 CELLS to consistently produce convex CYSTS under
simulated 3D embedded culture condition. Measures of
axiom use during CYSTOGENESIS provided a detailed
description of ISEA2 dynamic phenotype. Dysregulating
key CELL DEATH and DIVISION axioms led to disorganized
cystic forms that were reminiscent of the in vitro tumor
reconstruction phenotype. Unexpectedly, ISEA2's drive
for convexity made it less susceptible to, or more robust
against, the dysregulation of either axiom when compared
to its predecessor, ISEA1. It will be interesting to learn if
the mechanisms underlying epithelial cyst convexity in
cultures contribute to robustness against comparable
interventions. In addition, occasional disruption of one
activity in a minority of CELLS, as in Figures 10 and 11, had
consequences for the system (e.g., altered CYST morphol-
ogy) and for all other normal behaving CELLS. The average
axiom use patterns of all other CELLS changed. Upon
reflection, the observation could be expected. The actions
of all CELLS in a CLUSTER transforming into a CYST are net-
worked in space and time. An action of one CELL can affect
the action options of a nearby CELL at a future time. If a
CELL occasionally malfunctions, it has measurable conse-
quences, as shown in Figures 10 and 11. To the extent that
the mappings in Figure 1 are accepted as valid, we can
extend such observations to MDCK epithelial cells under-
going morphogenesis.
The results reaffirm that Axioms 5 and 6 play critical,
dominant roles in determining the CYSTOGENESIS pheno-
type. Also, as noted in Results, Axiom 1 was essential for
initial LUMINAL SPACE creation, and completely blocking its
use had a detrimental effect on CULTURE morphology. On
the other hand, Axioms 2–4 and 7 were nonessential for
CYSTOGENESIS in EMBEDDED CULTURE. Dysregulating or sim-
ply deleting the axioms did not patently alter the
CYSTOGENESIS phenotype. However, that does not mean
that the axioms were not parsimonious: they were essen-
tial to achieving targeted attributes of the other CULTURE
types—SUSPENSION, SURFACE, and OVERLAY—from [9].
Whether a similar relationship holds true for their biolog-
ical counterpart is unknown. However, it is clear that
MDCK cells under different culture conditions use some-
what different cell mechanisms depending on the specific
culture condition, which leads to different culture pheno-
types [2,30-32].
While reasonable mappings can be established from ISEA
to MDCK and MCF-10A mammary epithelial cell pheno-
types [16], ISEA axioms may not map well to other epithe-Page 16 of 21
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Axiom usage by ISEA2 during partial Axiom 5 dysregulationFigure 10
Axiom usage by ISEA2 during partial Axiom 5 dysregulation. Normalized axiom use frequencies are plotted versus 
simulation cycle as in Figure 9. Axiom numbers in circles are shown for each curve. *: dysregulated action. Left panels (A-C): p 
= 0.8. Right panels (D-F): p = 0.6. Top: axioms used most frequently. Middle: moderate use events. Bottom: Rare axiom use 
events. The curves are normalized use frequencies averaged over 100 Monte Carlo runs. In A and B, Axiom 5* usage frequen-
cies are magnified by a factor of 5.
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Axiom usage by ISEA2 during partial Axiom 6 dysregulationFigure 11
Axiom usage by ISEA2 during partial Axiom 6 dysregulation. Normalized axiom use frequencies are plotted versus 
simulation cycle as in Figures 9 and 10. Axiom numbers in circles are shown for each curve. *: dysregulated action. Left panels 
(A-C): p = 0.8. Right panels (D-F): p = 0.6. Top: axioms used most frequently. Middle: moderate use events. Bottom: Rare 
axiom use events. The curves are normalized use frequencies averaged over 100 Monte Carlo runs.
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cell cultures, cyst structures develop by a mechanism that
involves neither cell death nor proliferation [33]. Alveo-
lar-like cysts form by cell migration and aggregation, in
contrast to how cysts typically develop in MDCK cell cul-
tures. Those differences are mirrored in validated CELL
axiom specifications of the ISEAs and AT II analogues.
Unlike the ISEA CELLS, the AT II analogue [6] lacks CELL
DEATH and PROLIFERATION action options. They form CYSTS
exclusively by spatial rearrangement. Notwithstanding
those differences, their stable form similarities suggest
common mandates. For instance, ISEA and AT II ana-
logues do exhibit a common, essential feature: CELLS strive
to achieve and maintain lateral CELL-CELL contacts. Addi-
tional insight is anticipated when 2D simulations are
expanded to 3D.
Cell processes work together in ways that give rise to effec-
tive mandates that normal epithelial cells appear to fol-
low. Each mandate is assumed a consequence of the
interoperation of genetics and environmental factors.
How specific cell actions contribute to these mandates is
unclear. However, tracing CELL activities during ISEA2
simulations makes clear how their mandates, the targeted
attributes, are achieved. That clarity provides insight into
and plausible explanations of MDCK's morphogenic phe-
nomena. Because ISEA components and mechanisms are
coarse-grained, one ISEA2 axiom may map to many fine-
grain MDCK processes. Iterative refinement of ISEA2 so
that it achieves an expanded set of MDCK attributes will
improve and concretize the mappings from analogue to
MDCK cultures, potentially creating new knowledge.
Mappings from specifics of MDCK cultures (complex) to
analogue (simplified), however, will always be ambigu-
ous, a property of all referent-model pairs.
Moving forward, we suggest the following iterative refine-
ment protocol. It was used successfully herein and in pre-
vious studies [4-6,9,34]. The protocol supports adhering
to the guideline of parsimony which is important when
building a complex model. It is straightforward and so can
be used for refinement of any mechanistically focused,
agent-based biomimetic analogue. Basic steps are: 1) start
with a small but diverse set of in vitro attributes, static and
dynamic. They are the initial targeted attribute list. 2)
Posit coarse-grained, discrete mechanisms, requiring as
few components as is reasonable, that may generate anal-
ogous phenomena. 3) Instantiate (represent an abstrac-
tion by a concrete software instance) analogue
components and mechanisms. 4) Conduct experiments to
measure a variety of phenomena generated during execu-
tion. So doing establishes the degree of in silico-in vitro
phenotype overlap, and lack thereof. 5) Achieve a degree
of validation by satisfying a prespecified level of similarity
between in silico and targeted in vitro attributes. 6) Add
one or more new attributes (measurable phenomena) to
the targeted list until the analogue in step 5 is falsified.
Added attributes need to be at a similar level to and suffi-
ciently close to those already present so that it seems fea-
sible to achieve the expanded attribute list with as little
component reengineering as possible. Once the analogue
in step 5 is falsified, return to step 2.
The nature and organization of software components
within the ISEA framework, as illustrated in Figure 2, were
designed to facilitate iterative refinement of everything on
the right side of Figure 1. That process can concretize each
of the mappings from ISEA to MDCK counterparts. As the
process continues, following each round of validation,
more of what we know or think we know becomes instan-
tiated in the analogue. After many such rounds, the ana-
logue will mature as instantiated, working hypotheses of
how MDCK cystogenesis and pathologic transformations
occur. At that stage, it will have become an extensible,
interactive instantiation of available biological knowledge
about mechanisms and processes. It will have become an
executable knowledge embodiment. To achieve that
vision, it is essential that biomimetic components func-
tion (quasi-) autonomously, all or part of the time. That is
why CELLS are agents. Everything that a CELL needs to func-
tion (in a specified software environment) is contained
within its code. Absent that property, the mappings from
ISEA to MDCK cystogenesis mechanisms are not concre-
tizable, and so the mappings from ISEA to MDCK operat-
ing principles are forced to remain conceptual.
Finally, axiom use results show that at the same time, dif-
ferent CELLS within the same CULTURE are engaged in quite
different activities. The same is true in vitro; one MDCK
cell can be moving actively relative to its attached neigh-
bors while another is undergoing anoikis, and yet another
is initiating division. Simultaneously, polarized cells that
have achieved their mandates may begin downregulating
processes used earlier. It follows that the ensemble of
molecular biology details, such as gene and protein
expression levels, which enable those different activities
will themselves be different. Patterns detected in gene and
protein expression data averaged over all cells in an active
cyst may have little scientific value in answering such
questions as these. When and how does an epithelial cell
choose to switch from one activity to another? Why does
it choose one action rather than another? Are several
action options always available to each cell? Obtaining
plausible answers to these and related questions is essen-
tial to achieving deeper insight into epithelial morpho-
genesis and early cancer progression. As demonstrated,
the class of models presented herein provides a rigorous
platform to hypothesize, challenge, and refine plausible
answers. The causal chain of events responsible for most
simulated behaviors can be explored in detail, and assess-Page 19 of 21
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portable by in vitro evidence) or not.
Conclusion
The approach described herein provided for a hypothe-
sis—a theory—of how the collective consequences of
individual MDCK cell actions might give rise to systemic
in vitro phenotype. The causal chain of events responsible
for most ISEA behaviors could be explored in detail, and
assessments could be made of their relative roles during
simulation. Having that capability enabled us to develop
a detailed dynamic ISEA phenotype. The MDCK embed-
ded culture counterpart is problematic to obtain using
state-of-the-art in vitro methods. We expect future rounds
of model refinement and validation will strengthen in sil-
ico-to-in vitro mappings, thus providing a viable strategy
to gain deeper insight into the mechanistic basis of epithe-
lial cystogenesis, morphogenesis, and in vitro transforma-
tions.
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